bpc-157 randomized trial human Canada Research Guide 2026: Sourcing, and Compliance Pentadecapeptide BPC 157 (capitals) prevented
Description
Retrieved on Feb
While outcomes remain speculative, the mechanistic parallels continue to stimulate new investigative questions
They don't even belong in the same pharmacological category
&srotate=0)
And thats exactly what this compound does
And for the broader project of longevity medicine building a clinical practice that optimizes biology rather than reacting to disease the return of these compounds to legitimate access is a step in the right direction
It was bordering on scaremongering and harassment
